dcbs for cad in certain patients with large vessel de novo
DCBs for CAD in Certain Patients With Large Vessel De Novo
PARIS, France—Patients who have a high risk of bleeding due to older age, anticoagulation, or other factors but require treatment for de novo coronary artery lesions in large vessels could be candidates for drug-coated balloons (DCBs), researchers reported today at EuroPCR. Findings from the small ...
Send Inquiry
Drug-Coated Balloons in STEMI ‘Safe and Feasible’
Patients were randomized to DCB (n = 60) or DES (n = 60) if they had a de novo, non-severely calcified culprit lesion in a native coronary artery with residual stenosis of less than 50% after predilatation. More than 70% of patients had single-vessel disease, and all patients were randomized after predilatation.
Send Inquiry
Drug Coated Balloon-Only Strategy in De Novo Lesions
Objectives. We analyzed the efficacy of drug coated balloons (DCB) as a stand-alone-therapy in de novo lesions of large coronary arteries. DCBs seem to be an attractive alternative for the stent-free interventional treatment of de novo coronary artery disease (CAD). However, data regarding a DCB-only approach in de novo CAD are currently limited to vessels of small caliber.
Send Inquiry
ESC: DCB Works for De Novo Stenoses in Small Coronary Vessels
ESC: DCB Works for De Novo Stenoses in Small Coronary Vessels Established for in-stent restenosis, DCBs make their way to native coronary arteries
Send Inquiry
Coronary artery aneurysm formation after drug-coated
[4,5] Although studies have provided increasing evidence that DCB use is feasible for certain de novo coronary lesions, these studies have primarily focused on the treatment of small-vessel coronary artery disease (CAD) or on DCB use as part of a treatment strategy for bifurcation lesions. [2,6,7]
Send Inquiry
Drug-Coated Balloons Small-Vessel CAD | USC Journal
Percutaneous coronary intervention of small-vessel coronary artery disease (SVD) remains challenging due to difficulties with device delivery and high restenosis rate, even with the use of newer-generation drug-eluting stents. Drug-coated balloons represent an attractive emerging percutaneous coronary intervention option in patients with SVD.
Send Inquiry
Drug-Coated Balloons Small Coronary Vessel Interventions
Venetsanos et al. analysed a large cohort of 7,655 patients who received either a DCB (n=1,197 ... While evidence of the value of DCBs in patients presenting with ISR is ... Sim HW, Ananthakrishna R, Chan SP, et al. Treatment of very small de novo coronary artery disease with 2.0 mm drug-coated balloons showed 1-year clinical outcome comparable ...
Send Inquiry
Cardiac Interventions Today - Go Implant-Free in De Novo
Balloons coated with paclitaxel and iopromide as an excipient were originally developed for treating ISR; however, their potential for treating de novo coronary artery lesions was later demonstrated in large registry trials. 2-7 The BASKET-SMALL 2 trial (n = 758) was the first RCT with a primary clinical endpoint showing non-inferiority of DCBs ...
Send Inquiry
Coronary artery aneurysm formation after drug-coated
Coronary artery aneurysm formation after drug-coated balloon treatment of de novo lesions: Two case reports. ... Whereas increasing evidences show that DCB use was feasible in certain de novo coronary lesions. ... development following DCB treatment of de novo lesions. PATIENT CONCERNS: A 42-year-old male underwent delayed coronary angiography ...
Send Inquiry
Drug-coated balloon therapy in coronary and peripheral
Among patients with de novo coronary artery disease, convincing data from randomized trials to support DCB therapy is lacking, and the use of DCBs for this indication requires further investigation
Send InquiryDCBs for CAD in Certain Patients With Large Vessel De Novo
for de novo coronary artery lesions in large vessels could be candidates for drug-coated balloons (DCBs), researchers reported today at EuroPCR. Findings from the small, single-blind, randomized DEBUT trial show that, compared with BMS, DCBs offer such patients a lower risk of MACE at 9
Send InquiryDrug-eluting Balloon for the Treatment of de novo | tctmd.com
DCBs for CAD in Certain Patients With Large Vessel De Novo Disease?CRF is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives.
Send Inquiry
BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for
MUNICH, Germany—In patients with de novo lesions in small coronary arteries, a drug-coated balloon (DCB) provides results similar to those obtained with second-generation DES after successful predilatation, accordingDCBs for CAD in Certain Patients With Large Vessel De Novo Disease?
Send InquiryDrug Coated Balloon-Only Strategy in De Novo Lesions of Large
In this study, 103 patients with de novo CAD were enrolled and treated with a DCB-only strategy. In comparison to our registry, the Valentines IIWe believe that the low TLR rates after DCB-only angioplasty in our patients with de novo lesions in large coronary arteries can be explained by the
Send Inquiry
Drug-coated balloon angioplasty for de novo small vessel disease
of drug-coated balloons (DCBs) for real-world de novo small vessel diseases including chronic totalDCB angioplasty has been reported to be effective in the treatment of de novo small vesselGuidelines for elective percutaneous coronary intervention in patients with stable coronary artery
Send Inquiry
Innovatiivinen lääkepallo ei edellytä stentin asettamista suoneen
*** DCBs for CAD in Certain Patients With Large Vessel De Novo Disease?
Send Inquiry
Drug-coated balloon angioplasty for de novo small vessel
| The aim of this study is to validate the efficacy of drug-coated balloons (DCBs) for real-world de novo small vessel diseases including chronic totalThe SeQuent Please Small Vessel 'PCB only' Registry was an international, prospective, multicentre registry enrolling patients with de novo
Send Inquiry
Drug-Coated Balloons Small-Vessel CAD | USC Journal
Small-vessel coronary artery disease.trial, bare metal stents (BMS) were not superior to BA in 404 patients with SVD.1 A large meta-analysis published in 2005, however, whichFor the treatment of obstructive CAD, DCBs were first considered in 2003 as a potential treatment for ISR after BMS and
Send InquiryTreatment of Very Small De Novo Coronary Artery | PubFacts
Methods: All patients treated with 2.0 mm DCB or 2.0 mm DES for very small vessel de novo CAD from July 2014 to June 2016 were included in this study.Results: A total of 87 patients (96 lesions) were implanted with 2.0 mm DCBs and 200 patients (223 lesions) were implanted with 2.0 mm DESs
Send Inquiry
Staged Treatment of a STEMI patient with multi-vessel disease
A de-novo critical stenosis of the ostial LAD, caused by plaque shift, was found and stenting with involvement of the LM was deemed necessary. The large diameter gap between LM and LAD, assessed by IVUS, posed critical issues in the choice of the stent diameter.
Send Inquiry